Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies

Chimeric antigen receptor T-cell (CAR-T) therapy is an exciting development in the field of cancer immunology and has received a lot of interest in recent years. Many time-to-event (TTE) endpoints related to relapse, disease progression, and remission are analyzed in CAR-T studies to assess treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yimei, Hwang, Wei-Ting, Maude, Shannon L., Teachey, David T., Frey, Noelle V., Myers, Regina M., Barz Leahy, Allison, Liu, Hongyan, Porter, David L., Grupp, Stephan A., Shaw, Pamela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481718/
https://www.ncbi.nlm.nih.gov/pubmed/35838646
http://dx.doi.org/10.1158/1078-0432.CCR-22-0560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481718/
https://www.ncbi.nlm.nih.gov/pubmed/35838646
http://dx.doi.org/10.1158/1078-0432.CCR-22-0560

Ejemplares similares